Athene Holding Ltd.
ATHS NYSE Life Insurance Financials FY2016βFY2025
What Athene Holding Ltd. does
No business description yet.
- Legal name
- Athene Holding Ltd.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0001527469-26-000013
0001527469
Revenue and margins
Athene Holding Ltd. had $25.7B of revenue in fiscal 2025, up 24.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Athene Holding Ltd. returned $752M to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Athene Holding Ltd. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $9.5B | $7.8B | $13.0B | $14.3B | $16.9B |
| Debt incl. finance leases | $3.0B | $3.7B | $4.2B | $6.3B | $7.8B |
| Debt / equity | 0.1x | 0.5x | 0.3x | 0.4x | 0.4x |
| Total assets | $235.1B | $243.9B | $300.6B | $363.3B | $442.2B |
| Total liabilities | $213.0B | $233.4B | $279.3B | $337.5B | $406.6B |
| Shareholders' equity | $20.1B | $7.2B | $13.8B | $16.4B | $20.5B |
| Net debt (β = net cash) | β$6.5B | β$4.1B | β$8.8B | β$8.0B | β$9.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | β / 5 | β / 5 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β0.5% | β1.9% | β1.6% | β0.4% | β1.5% | β2.9% | β4.7% | β0.1% | 0.5% | β0.6% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $4.1B | $8.8B | $6.6B | $16.3B | $14.8B | $26.3B | $7.6B | $28.2B | $20.7B | $25.7B |
| Provision for credit losses | β | β | $0.0M | $0.0M | $96.0M | β$53.0M | $227M | $335M | β | β |
| Pretax income | $712M | $1.5B | $1.2B | $2.3B | $2.2B | $4.2B | β$5.7B | $4.6B | $5.6B | $5.1B |
| Income tax | β$61.0M | $106M | $122M | $117M | $285M | $386M | β$646M | β$1.2B | $730M | $886M |
| Net income | $773M | $1.4B | $1.1B | $2.2B | $1.5B | $3.9B | β$5.0B | $4.7B | $3.5B | $2.7B |
| Net income to common | β | $1.4B | $1.1B | $2.1B | $1.4B | $3.7B | β$3.1B | $4.5B | $3.3B | $2.6B |
| Cash flow | ||||||||||
| Cash from operations | $1.2B | $3.2B | $2.9B | $2.7B | $4.2B | $10.3B | $6.3B | $5.0B | $1.9B | $5.2B |
| Stock-based compensation | $84.0M | $45.0M | $26.0M | β | β | β | β | β | β | β |
| Share buybacks | β | β | $105M | $832M | $428M | $8.0M | $0.0M | $0.0M | β | β |
| Dividends paid | β | β | β | β | $0.0M | $0.0M | $1.3B | $937M | $452M | $752M |
| Dividends and buybacks | β | β | $105M | $832M | $428M | $8.0M | $1.3B | $937M | $452M | $752M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $2.5B | $5.0B | $3.4B | $4.8B | $7.7B | $9.5B | $7.8B | $13.0B | $14.3B | $16.9B |
| Total debt | β | β | β | $1.5B | $2.0B | $3.0B | $3.7B | $4.2B | $6.3B | $7.8B |
| Goodwill | β | β | β | β | β | $0.0M | $4.1B | $4.1B | $4.1B | $4.1B |
| Intangible assets | β | β | β | β | β | β | β | β | $1.7B | $1.6B |
| Total assets | $86.7B | $100.2B | $125.5B | $146.9B | $202.8B | $235.1B | $243.9B | $300.6B | $363.3B | $442.2B |
| Total liabilities | $79.8B | $91.0B | $117.2B | $132.7B | $182.6B | $213.0B | $233.4B | $279.3B | $337.5B | $406.6B |
| Shareholders' equity | $6.9B | $9.2B | $8.3B | $13.4B | $18.7B | $20.1B | $7.2B | $13.8B | $16.4B | $20.5B |
| Margins | ||||||||||
| Net margin | 18.8% | 15.5% | 15.9% | 13.4% | 10.4% | 14.7% | β65.8% | 16.5% | 16.7% | 10.6% |
| Returns | ||||||||||
| Return on equity | 11.3% | 16.9% | 12.0% | 20.0% | 9.6% | 19.9% | β36.8% | 44.4% | 22.9% | 14.7% |
| Return on assets | 0.9% | 1.5% | 0.9% | 1.6% | 0.9% | 1.8% | β2.1% | 1.7% | 1.0% | 0.7% |
| Return on tangible equity | 11.3% | 14.7% | 12.7% | 16.0% | 7.8% | 18.5% | β98.4% | 45.9% | 31.0% | 17.8% |
| Growth | ||||||||||
| Revenue growth | β | 114.1% | β24.5% | 145.0% | β9.2% | 78.3% | β71.0% | 269.9% | β26.6% | 24.1% |
| Net income growth | β | 75.7% | β22.5% | 106.3% | β29.1% | 150.4% | β230.0% | β | β25.8% | β21.7% |
| Financial health | ||||||||||
| Debt / equity | β | β | β | 0.1x | 0.1x | 0.1x | 0.5x | 0.3x | 0.4x | 0.4x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 2.0% | 0.5% | 0.4% | β | β | β | β | β | β | β |
| Quality scores | ||||||||||
| Accruals ratio | β0.5% | β1.9% | β1.6% | β0.4% | β1.5% | β2.9% | β4.7% | β0.1% | 0.5% | β0.6% |
Source: SEC EDGAR XBRL filings (CIK 0001527469). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.